Indoco Remedies Ltd.

NSE: INDOCO | BSE: 532612 | ISIN: INE873D01024 | Industry: Pharmaceuticals
| Momentum Trap
290.6000 0.45 (0.16%)
NSE Oct 03, 2025 15:31 PM
Volume: 20,202
 

290.60
0.16%
ICICI Securities Limited
India formulations growth core to overall growth Domestic formulations (~63% of FY20 revenues) grew at 6.5% CAGR in FY16-20. The subdued growth can be attributed to high concentration of acute therapies and one of the lowest MR productivity. With a market share of ~0.7% and overall rank of 29, the company is still a marginal player with some top brands in smaller categories like stomatologicals. However, with a positive outcome of restructuring exercise and likely improvement in MR productivity besides therapy calibration, we expect Indian formulations to...
Indoco Remedies Ltd. has an average target of 325.00 from 2 brokers.
More from Indoco Remedies Ltd.
Recommended